Related Experiment Video
Updated: Jun 13, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Update: immunological strategies for prostate cancer
Charles G Drake1, Emmanuel S Antonarakis
1Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 1650 Orleans Street, CRB1-410, Baltimore, MD, 21231, USA. cdrake@jhmi.edu
Current Urology Reports
|April 29, 2010
Summary
Prostate cancer immunotherapy offers new hope for targeted treatment. Research explores various vaccines and immune checkpoint inhibitors, aiming for effective tumor destruction with minimal side effects.
Area of Science:
- Oncology
- Immunology
Background:
- Prostate cancer is a leading cause of cancer death in US men, with limited treatment options beyond surgery, radiation, and hormonal therapy.
- Docetaxel chemotherapy offers a survival advantage for advanced disease, but the search for novel treatments, including immunotherapy, is ongoing.
- Prostate cancer, unlike traditionally immune-responsive cancers, may express unique antigens that can be targeted by the immune system.
Purpose of the Study:
- To summarize recent clinical developments in prostate cancer immunotherapy.
- To review various immunotherapy approaches, including dendritic cell, virus-based, DNA-based, and cell-based vaccines.
- To introduce immune checkpoint inhibitors as a potential therapeutic strategy.
Main Methods:
- Review of recent clinical developments in prostate cancer immunotherapy.
- Focus on dendritic cell vaccines, virus-based vaccines, DNA-based vaccines, and cell-based vaccines.
- Introduction to immune checkpoint targeting agents.
Main Results:
- Several prostate cancer immunotherapy agents have demonstrated significant survival benefits in clinical trials.
- One agent, Sipuleucel-T, was nearing FDA approval in 2010.
- The potential for targeted tumor cell destruction with reduced systemic toxicity is a key driver of enthusiasm.
Conclusions:
- Prostate cancer immunotherapy holds promise for targeted treatment.
- Various vaccine-based strategies and immune checkpoint inhibitors are under investigation.
- Realizing the full clinical potential of prostate cancer immunotherapy requires further development and validation.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...